176 related articles for article (PubMed ID: 22207577)
1. Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria.
Jiang J; Johnson LC; Knight J; Callahan MF; Riedel TJ; Holmes RP; Lowther WT
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(6):G637-43. PubMed ID: 22207577
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyproline metabolism in mouse models of primary hyperoxaluria.
Knight J; Holmes RP; Cramer SD; Takayama T; Salido E
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F688-93. PubMed ID: 22189945
[TBL] [Abstract][Full Text] [Related]
3. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.
Li X; Knight J; Fargue S; Buchalski B; Guan Z; Inscho EW; Liebow A; Fitzgerald K; Querbes W; Todd Lowther W; Holmes RP
Biochim Biophys Acta; 2016 Feb; 1862(2):233-9. PubMed ID: 26655602
[TBL] [Abstract][Full Text] [Related]
5. Effect of Vitamin B2-Deficient Diet on Hydroxyproline- or Obesity-Induced Hyperoxaluria in Mice.
Uebanso T; Suyama M; Shimohata T; Mawatari K; Takahashi A
Mol Nutr Food Res; 2021 Aug; 65(15):e2100226. PubMed ID: 34110671
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.
Fargue S; Milliner DS; Knight J; Olson JB; Lowther WT; Holmes RP
J Am Soc Nephrol; 2018 Jun; 29(6):1615-1623. PubMed ID: 29588429
[No Abstract] [Full Text] [Related]
7. Glyoxylate is a substrate of the sulfate-oxalate exchanger, sat-1, and increases its expression in HepG2 cells.
Schnedler N; Burckhardt G; Burckhardt BC
J Hepatol; 2011 Mar; 54(3):513-20. PubMed ID: 21093948
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria.
Knight J; Holmes RP
Am J Nephrol; 2005; 25(2):171-5. PubMed ID: 15849464
[TBL] [Abstract][Full Text] [Related]
9. Glycolate and glyoxylate metabolism in HepG2 cells.
Baker PR; Cramer SD; Kennedy M; Assimos DG; Holmes RP
Am J Physiol Cell Physiol; 2004 Nov; 287(5):C1359-65. PubMed ID: 15240345
[TBL] [Abstract][Full Text] [Related]
10. Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.
Summitt CB; Johnson LC; Jönsson TJ; Parsonage D; Holmes RP; Lowther WT
Biochem J; 2015 Mar; 466(2):273-81. PubMed ID: 25697095
[TBL] [Abstract][Full Text] [Related]
11. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
Kukreja A; Lasaro M; Cobaugh C; Forbes C; Tang JP; Gao X; Martin-Higueras C; Pey AL; Salido E; Sobolov S; Subramanian RR
Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
[TBL] [Abstract][Full Text] [Related]
12. Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria.
Gianmoena K; Gasparoni N; Jashari A; Gabrys P; Grgas K; Ghallab A; Nordström K; Gasparoni G; Reinders J; Edlund K; Godoy P; Schriewer A; Hayen H; Hudert CA; Damm G; Seehofer D; Weiss TS; Boor P; Anders HJ; Motrapu M; Jansen P; Schiergens TS; Falk-Paulsen M; Rosenstiel P; Lisowski C; Salido E; Marchan R; Walter J; Hengstler JG; Cadenas C
Cell Rep; 2021 Aug; 36(8):109526. PubMed ID: 34433051
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of Oxalate in Humans: A Potential Role Kynurenine Aminotransferase/Glutamine Transaminase/Cysteine Conjugate Betalyase Plays in Hyperoxaluria.
Han Q; Yang C; Lu J; Zhang Y; Li J
Curr Med Chem; 2019; 26(26):4944-4963. PubMed ID: 30907303
[TBL] [Abstract][Full Text] [Related]
14. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.
Liebow A; Li X; Racie T; Hettinger J; Bettencourt BR; Najafian N; Haslett P; Fitzgerald K; Holmes RP; Erbe D; Querbes W; Knight J
J Am Soc Nephrol; 2017 Feb; 28(2):494-503. PubMed ID: 27432743
[TBL] [Abstract][Full Text] [Related]
15. 4-Hydroxyproline metabolism and glyoxylate production: A target for substrate depletion in primary hyperoxaluria?
Coulter-Mackie MB
Kidney Int; 2006 Dec; 70(11):1891-3. PubMed ID: 17130820
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.
Bons J; Tadeo A; Scott GK; Teramayi F; Tanner JJ; Schilling B; Benz CC; Ellerby LM
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166848. PubMed ID: 37586438
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
Dutta C; Avitahl-Curtis N; Pursell N; Larsson Cohen M; Holmes B; Diwanji R; Zhou W; Apponi L; Koser M; Ying B; Chen D; Shui X; Saxena U; Cyr WA; Shah A; Nazef N; Wang W; Abrams M; Dudek H; Salido E; Brown BD; Lai C
Mol Ther; 2016 Apr; 24(4):770-8. PubMed ID: 26758691
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperoxalurias: disorders of glyoxylate detoxification.
Salido E; Pey AL; Rodriguez R; Lorenzo V
Biochim Biophys Acta; 2012 Sep; 1822(9):1453-64. PubMed ID: 22446032
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Hydroxy-L-proline (HYP) analogs in the treatment of primary hyperoxaluria in Drosophila Melanogaster.
Yang H; Male M; Li Y; Wang N; Zhao C; Jin S; Hu J; Chen Z; Ye Z; Xu H
BMC Nephrol; 2018 Jul; 19(1):167. PubMed ID: 29980178
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyproline ingestion and urinary oxalate and glycolate excretion.
Knight J; Jiang J; Assimos DG; Holmes RP
Kidney Int; 2006 Dec; 70(11):1929-34. PubMed ID: 17021603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
